BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2138559)

  • 41. B cells from CBA/N mice do not proliferate following ligation of CD40.
    Hasbold J; Klaus GG
    Eur J Immunol; 1994 Jan; 24(1):152-7. PubMed ID: 7517360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
    Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
    J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The identity of IgE receptors (Fc epsilon RII) that mediate cellular activation of human macrophages: evidence against a role for CD23.
    MacDermot J; Joseph S; Dollery CT
    Mol Immunol; 1992 Jan; 29(1):71-6. PubMed ID: 1530985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of membrane and soluble CD23 in lymphocyte physiology.
    Gordon J; Cairns JA; Liu YJ; Flores-Romo L; MacLennan IC; Jansen KU; Bonnefoy JY
    Monogr Allergy; 1991; 29():156-68. PubMed ID: 1836533
    [No Abstract]   [Full Text] [Related]  

  • 45. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production.
    Zhang K; Clark EA; Saxon A
    J Immunol; 1991 Mar; 146(6):1836-42. PubMed ID: 1706382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE.
    Sarfati M; Delespesse G
    J Immunol; 1988 Oct; 141(7):2195-9. PubMed ID: 2971721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thymic epithelial cell-derived supernatants sustain the maturation of human prothymocytes: involvement of interleukin 1 and CD23.
    Dalloul AH; Fourcade C; Debré P; Mossalayi MD
    Eur J Immunol; 1991 Oct; 21(10):2633-6. PubMed ID: 1717288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of type II Fc gamma receptor expression on activated human B lymphocytes.
    Sármay G; Rozsnyay Z; Szabó I; Biró A; Gergely J
    Eur J Immunol; 1991 Mar; 21(3):541-9. PubMed ID: 1826259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
    Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J
    Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD77: an antigen of germinal center B cells entering apoptosis.
    Mangeney M; Richard Y; Coulaud D; Tursz T; Wiels J
    Eur J Immunol; 1991 May; 21(5):1131-40. PubMed ID: 1709864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
    Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
    J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma.
    Chrétien I; Pène J; Brière F; De Waal Malefijt R; Rousset F; De Vries JE
    Eur J Immunol; 1990 Feb; 20(2):243-51. PubMed ID: 2138081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human recombinant CD23 (full-length and soluble forms) expressed in insect cells bind IgE.
    Jansen KU; Shields J; Graber P; Pochon S; Aubry JP; Bonnefoy JY
    Monogr Allergy; 1991; 29():50-62. PubMed ID: 1836538
    [No Abstract]   [Full Text] [Related]  

  • 54. Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth.
    Guy GR; Gordon J
    Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6239-43. PubMed ID: 2957693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble CD23/BLAST-2 (S-CD23/Blast-2) and its role in B cell proliferation.
    Swendeman SL; Thorley-Lawson D
    Curr Top Microbiol Immunol; 1988; 141():157-64. PubMed ID: 2975205
    [No Abstract]   [Full Text] [Related]  

  • 56. Surface molecules involved in B lymphocyte function.
    Möller P; Eichelmann A; Moldenhauer G
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):365-72. PubMed ID: 1836292
    [No Abstract]   [Full Text] [Related]  

  • 57. Expression of human recombinant CD23 in insect cells.
    Jansen KU; Shields J; Gordon J; Cairns J; Graber P; Bonnefoy JY
    J Recept Res; 1991; 11(1-4):507-20. PubMed ID: 1832188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of interleukin-3-dependent growth of CD34+ acute myelogenous leukemia cells by recombinant soluble CD23.
    Mossalayi MD; Merle-Beral H; Dalloul AH; Arock M; Michel A; Hofstetter H; Debre P
    Ann N Y Acad Sci; 1991; 628():362-7. PubMed ID: 1712558
    [No Abstract]   [Full Text] [Related]  

  • 59. CD23 (FcepsilonRII) release from cell membranes is mediated by a membrane-bound metalloprotease.
    Marolewski AE; Buckle DR; Christie G; Earnshaw DL; Flamberg PL; Marshall LA; Smith DG; Mayer RJ
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):573-9. PubMed ID: 9677315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD23: novel disease marker with a split personality.
    Gordon J
    Clin Exp Immunol; 1991 Dec; 86(3):356-9. PubMed ID: 1836159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.